Rodman & Renshaw Upgrades Insulet

Rodman & Renshaw upgraded its Insulet PODD rating to Market Perform in a research report published today. In the report, Rodman & Renshaw states, "We are upgrading Insulet to a Market Perform rating. Our core concerns of over-enthusiastic Street expectations remain, however, the stock has reached our price target and hence we are moving to the sidelines." Shares of Insulet were trading at $18.55 at the time of posting, up 0.60% from Tuesday's market close.